Adaptimmune, a leader in T cell therapy, is dedicated to transforming cancer immunotherapy with affinity enhanced T cell receptors. The company proudly supports Cancer Research Institute's annual global awareness campaign, Cancer Immunotherapy Month.

*Immunotherapy results may vary from patient to patient.

Top